Unum cell therapy

Author: kfts

August undefined, 2024

WebCogent Biosciences uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor technology, is expected to enter Phase I clinical testing in the coming months to assess safety and … WebCision - MediaStudio View Media - PR Newswire

National Center for Biotechnology Information

WebMay 9, 2024 · In contrast to other T cell therapy approaches for cancer that are limited to a single cancer cell surface target and, therefore, treat a narrow set of tumors, Unum’s approach is not restricted ... WebOct 27, 2014 · Unum Therapeutics Inc.'s ACTR platform offers an approach for generating controllable T cell therapies that could be safer and applicable to a broader range of cancers than CAR- and TCR-based immunotherapies. The company debuted last week with a $12 million series A round co-led by Atlas Venture and Fidelity Biosciences. The round will … sun city estate sales company

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

WebNational Center for Biotechnology Information WebAug 31, 2024 · Unum Therapeutics' novel cell therapy programs address the major scientific obstacles in traditional T cell therapies. Scientists have discovered that the solid tumor … WebJan 13, 2015 · Bellicum Pharmaceuticals (NASDAQ: BLCM) designed a “switch” to control the the activation and proliferation of the CAR-T cells. Unum Therapeutics equipped T cells with a “socket”, known as CD16, to load the Fc portion of monoclonal antibodies [3]. This technology, known as ACTR, enables T cells to attack tumor cells in an antibody ... sun city festival clubs

Sotio Acquires Unum Therapeutics Cell-Based Therapy Assets

WebOct 21, 2014 · October 21, 2014 By Krystle Vermes, BioSpace.com Breaking News Staff Cambridge-based Unum Therapeutics, which is dedicated to using cellular … WebAt the American Cancer Society, we have a vision to end cancer as we know it, for everyone. We're improving the lives of cancer patients and their families through advocacy, research, and patient support to ensure that everyone has an opportunity to … sun city festival lady puttersWebMar 2, 2024 · Cell therapy developer Unum Therapeutics will lay off 43 employees in a research pivot, announcing Monday a restructuring designed to focus the Cambridge, … palm beach county fl elections

"WebOct 8, 2024 · BUILDING A PIPELINE OF CELLULAR AND REGENERATIVE THERAPIES. Launched earlier this year in May 2024, the SingHealth Duke-NUS Cell Therapy Centre … " - Unum cell therapy

Unum cell therapy

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

WebAug 31, 2024 · Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO PR Newswire Aug 31, 2024 7:30 AM EDT Transaction focused on the BOXR technology including lead program BOXR1030 Company fully focused on the development of small molecule precision kinase inhibitors to treat a range of genetically driven diseases … WebJan 29, 2024 · Unum’s novel proprietary technologies include Antibody-Coupled T cell Receptor (ACTR), an autologous engineered T-cell therapy that combines the cell-killing …

Did you know?

WebUnum Therapeutics Transfers BOXR Cell-Based Therapy Technology To SOTIO For $8.1M And Up To $3.4M Of Milestone Payments Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO CAMBRIDGE, Mass., Aug. 31, 2024 /PRNewswire/ -- Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing WebAug 31, 2024 · Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO Transaction focused on the BOXR technology including lead program BOXR1030 Company fully focused on the development of small mol...

WebCAMBRIDGE, MA, October 27, 2024 --(BUSINESS WIRE)--Unum Therapeutics Inc., a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat multiple cancers, today announced that the Company will be presenting on its Antibody-Coupled T cell Receptor (ACTR) platform at the 2024 AACR-NCI-EORTC International … WebResults: Median duration of leukopenia, neutropenia, lymphopenia, anemia, and thrombocytopenia was 49, 9, 117.5, 125, and 95.5 days after CAR-T infusion, respectively. Filgrastim was used in 63% of patients, and 50% of patients received red cell or platelet transfusions. With the exception of neutropenia, increase in the duration of cytopenia ...

WebThe opportunity for obe-cel extends beyond adult ALL. Obe-cel is currently being investigated in ongoing clinical studies for B-NHL indications and pediatric ALL. Alongside obe-cel, Autolus is progressing a number of pipeline assets both in preclinical and clinical development across hematological malignancies and solid tumors. WebChimeric antigen receptor (CAR) T-cell therapy treats certain cancers by turning your T-lymphocytes or T-cells into more efficient cancer-fighting machines. While researchers are still collecting long-term data, CAR T-cell therapy is proving to be a very effective way of treating certain blood cancers. Your T-cells are white blood cells in your ...

Webtherapy of HNSCC. However, while the HER2.CAR T cells they manufactured killed HER2-positive cell lines, there was minimal antitumor effect against established tumors in a xenogeneic mouse model. CAR T cells can be rendered more cytotoxic by genetic modiﬁcation to coexpress inﬂam-matory cytokines, but this canlead to poten-

WebAug 31, 2024 · SOTIO will establish a T cell therapy R&D Center of Excellence in Cambridge, Massachusetts. Unum’s former chief technology officer Geoff Hodge to join SOTIO to lead … sun city festival for saleWebNov 4, 2024 · Unum Therapeutics Inc. (UMRX), a clinical-stage biopharmaceutical company focused on developing curative cell therapies for cancer, today announced a strategic shift to focus development on its ACTR and BOXR product candidates in solid tumors and supportive platform capabilities. “We are uniquely positioned to address the challenge of … sun city festival new homesWebAug 31, 2024 · PPF-owned company SOTIO has acquired the rights to use the BOXR CAR-T platform and products from Cambridge-based Unum Therapeutics. Under the deal, SOTIO … sun city festival hideawayWebCAMBRIDGE, Mass., Aug. 31, 2024 /PRNewswire/ -- Unum Therapeutics Inc. (Nasdaq: UMRX), a biopharmaceutical company focused on developing novel, best-in-class … palm beach county fleet managementWebGuruFocus Article or News written by PRNewswire and the topic is about: sun city floor plans georgetown texasWebNational Center for Biotechnology Information palm beach county fl gis dataWebOct 21, 2014 · As the promise of harnessing the immune system to fight cancer grabs headlines around the industry, venture stalwarts Fidelity Biosciences and Atlas Venture have teamed up to launch Unum ... sun city festival by del webb buckeye